SCROLL

关于我们

创建全新的药物
研发平台

利用在CRO业务中积累的药物开发专有技术，以及覆盖亚洲，非洲和澳大利亚等地区的独特全球网络，以为实现分散式临床试验（DCT）而开发EDC，e-Consent，ePRO和CTMS等系统。
将这些技术结合起来，以创建一个全新的药物研发平台。

通过支持全世界所需的尖端药物研发，并营造全球临床试验环境，Remedy集团一直致力于解决福利，教育和健康科学方面的问题。

关于我们

业务详情

业务详情

Column

Global development with a focus on Asia, and the latest information on regenerative medicine.

Regenerative Medicine Column

ISSCR Special Edition:Regenerative Medicine and list of Regenerative Medicine Products Approved in Japan

This article is a special edition of the Regenerative Medicine Column distributed at the ISSCR Tokyo International Symposium 2021 held in October 2021. It introduces Remedy's Approach to Regenerative Medicine and list of Regenerative Medicine Products Approved in Japan.

  • Regenerative Medicine Product
  • Laws
  • Product

Global Newsletter

Latin America, a region of opportunities to conduct Clinical Trials.

One of the continents that has been gaining more relevance for clinical trials in recent times has been Latin America, but to better understand this market let's start with some relevant data.

  • LatinAmerica
  • Market

Global Newsletter

Volume of importing medical devices and updated medical device regulations in Thailand

According to the Plastic Institute of Thailand, Thailand's medical device imports grew by about 23% in the 2Q of 2021. And is expected to average 6.5% per year due to the aging of the population, rising demand for healthcare.

  • Thailand
  • Medical Equipment
  • Laws
Column Archive

招聘

我们正在世界各地
寻找与我们并肩作战的伙伴。

Remedy集团一直在寻找与我们理念一致，能够取得成果并愿意共同参与世界竞争的人才。

招聘信息（別ウインドウで開きます）
Remedy集团的信息发布网站
LiGHTHOUSE

我们正在积极宣传肿瘤学和再生医学方法，包括其工作方式。

官方社交媒体
  • Facebook
  • Twitter
  • YouTube
  • LinkedIn

从业务详情和专栏更新到招聘信息，提供广泛的资讯。

电邮杂志「Global Newsletter」
免费订阅　申请表格

免费提供来自亚洲和世界各地的临床试验指南修订及其它最新资讯。